Abstract
Systemic AL amyloidosis is associated with nearly 15% of cases of multiple myeloma, but data on the frequency and significance of amyloid deposits in the bone marrow of patients affected by multiple myeloma without clinical signs of systemic amyloidosis are scanty. Bone marrow smears of 166 unselected patients affected by multiple myeloma (126 at diagnosis and 40 after treatment) were stained with Congo red and studied by transmission and birefringence microscopy. Both focal and diffuse storages were considered positive. Overall, 67 patients were positive and 99 were negative to Congo red and apple-green birefringence. In particular, 51 of the 126 patients studied at diagnosis and 16 of the 40 patients with advanced disease were positive. Seventeen patients were reassessed after a mean follow-up of 32 months (range: 6–91): disappearance of amyloid deposits was verified in three cases, all responsive to bortezomib-based regimens. The preliminary data available suggest that amyloid deposition in the marrow of myeloma patients is frequent, as it can be traced in nearly 40% of cases. We failed to find correlations between bone marrow amyloid deposits and immunoglobulin type, disease stage, plasma cells percentage, hemoglobin, calcium, creatinine, albumin, or β2microglobulin. Significantly higher incidence of moderate/severe peripheral neuropathy was found in patients with marrow amyloid exposed to potentially neurotoxic antineoplastic agents. Further studies and prolonged follow-up are needed to validate our findings and to define possible prognostic aspects.
Similar content being viewed by others
References
Müller MS, Geibel A, Neumann HPH, Kühnemund A, Schmitt-Gräff A, Bӧhm J, Engelhardt M (2006) Primary (AL) amyloidosis in plasma cell disorders. The Oncologist 11:824–830
Cohen AS (1995) Amyloidosis. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds) Hematology. McGraw-Hill, USA, pp 1137–1146
Kyle RA, Gertz MA (1995) Primary sistemic amyloidosis: clinical and laboratory features in 474 cases. Sem Hematol 32:45–59
Kyle RA (1995) Amyloidosis. Circulation 91:1269–1271
Solomon A, Frangione B, Franklin EC (1982) Bence Jones proteins and light chain of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chain with amyloidosis AL (lambda). J Clin Invest 70:453–460
Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G (2002) Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment. Blood 100:948–953
Comenzo RL, Zhang Y, Martinez C, Osman K, Herrera GA (2001) The tropism of organ involvement in primary systemic amyloidosis: contribution of Ig VL germ line gene use and clonal plasma cell burden. Blood 98:714–720
Dobson CM (2003) Protein folding and misfolding. Nature 426:884–890
Merlini G, Berlotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596
Invernizzi R, Palladini G, Benatti C, Travaglino E, Nuvolone M, Merlini G (2006) Bone marrow amyloidosis. Haematologica 91(Suppl.5):23
Swan N, Skimmer M, O’Hara CJ (2003) Bone marrow core biopsy specimens in AL (primary) amyloidosis. Am J Clin Pathol 120:610–616
Reece DE, Sanchorawala V, Hegenbart U, Merlini G, Palladini G, Fermand JP, Vescio RA, Liu X, Elsayed YA, Cakana A, Comenzo RL (2009) Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study. Blood 114:1489–1497
van Rhee F, Dhodapkar M, Shaughnessy JD Jr, Anaissie E, Siegel D, Hoering A, Zeldis J, Jenkins B, Singhal S, Mehta J, Crowley J, Jagannath S, Barlogie B (2008) First thalidomide clinical trial in multiple myeloma: a decade. Blood 112:1035–1038
Acknowledgments
We wish to thank Dr. Mauro Bianchini from the State Medical Library in Rome and Dr. Antonio Risitano from the Hematology of the University Federico II in Naples for their technical support and helpful suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petruzziello, F., Zeppa, P., Catalano, L. et al. Amyloid in bone marrow smears of patients affected by multiple myeloma. Ann Hematol 89, 469–474 (2010). https://doi.org/10.1007/s00277-009-0857-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-009-0857-9